The L10F mutation in angiotensinogen alters the kinetics of the renin-angiotensin system, potentially promoting preeclampsia in carriers.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for L10F-driven preeclampsia risk in models; human validation required before any clinical inference.
Inoue et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: